GE HealthCare Reports the US FDA’s Approval of Flyrcado (Flurpiridaz F 18) PET Radiotracer for Improved CAD Diagnosis

Shots: The US FDA has approved Flyrcado injection as a PET MPI agent to diagnose CAD, with its launch planned in early 2025 The effectiveness of Flyrcado was assessed under the P-III (AURORA) study in comparison with both invasive coronary angiography as a standard and SPECT MPI to identify CAD In addition, GE HealthCare secured…

ByDipanshu DixitSeptember 27, 2024

TOP 20

Top 20 Diagnostic Companies of 2024 

Shots:  Propelled by unceasing innovations and inch-perfect precision, the diagnostic industry is advancing at an astonishing pace In 2023, the global diagnostic test market size was valued at $210.58B and is envisioned to reach $284.38B by 2033, registering a CAGR of 3.05 percent from 2024 to 2033. Roche reclaims its first position with a revenue…

ByPrince GiriMay 23, 2024

TOP 20

Top 20 Diagnostics Companies Based on 2021 Revenue

The diagnostic companies continued to serve the high demand for diagnostic testing throughout the COVID-19 pandemic in 2021 Siemens Healthineers, Roche, GE Healthcare, and Abbott were the top players in the race for the global diagnostic companies PharmaShots has compiled a list of the top 20 diagnostics Companies based on their 2021 revenue in the…

ByPrince GiriJune 9, 2022

TOP 20

Top 20 Diagnostics Companies Based on 2020 Revenue

The extraordinary demand for COVID-19 testing kits that were seen in 2020 and is yet to subside in 2021 resulted in many of the world's biggest diagnostics companies being thrust into the limelight Siemens Healthineers- GE Healthcare- Roche- and Abbott are the top players in the race of the global diagnostic companies. The companies are…

ByPrince GiriJune 10, 2021

TOP 20

Top 20 Diagnostics Companies Based on 2019 Revenue

Diagnostics has emerged as one of the largest and fastest-growing segments with evolving diseases. The segment has played a vital role in diagnosing growing and ageing global population with increasing health expenditure and more prevalent lifestyle ailments including obesity- cancer- and cardiovascular diseases. Our team at PharmaShots has compiled a list of top 20 diagnostics companies based…

ByPrince GiriJune 12, 2020

TOP 20

Top 20 Medical Device Companies Based on 2019 Revenue

The Medical device market is growing with evolving needs of patients and with their emerging diseases encouraging them to develop novel and innovative therapies or devices for maintaining quality of life. The ledger for 2019 of medical devices has shown changes for multiple companies but the position for Medtronic remains same to be one top…

ByPrince GiriMay 22, 2020

INSIGHTS+

PharmaShots’ Key Highlights of Fourth Quarter 2019

1. Pfizer Launched its Zirabev (biosimilar, bevacizumab) in the US by the year end 2019 Date - Oct 01, 2019 Product - Zirabev (biosimilar, bevacizumab) The biosimilar was launched in the US on Dec 31, 2019 following the settlement between Genentech and Pfizer granting all global rights of the product to the Pfizer. In Sept 2019,…

BySenior EditorJanuary 24, 2020

TOP 20

Top 20 Diagnostics Companies Based On 2018 Revenue

With the era of growing diseases- Diagnostics have played a vital role in diagnosing multiple diseases and disorders. The healthcare system is changing- with a greater focus on value- reducing errors and giving more cost-effective care and treatments. The Diagnostic ledger has not changed much in comparison to 2017. Roche Diagnostics holds to be at…

ByPrince GiriJuly 19, 2019

GE HealthCare Reports the US FDA’s Approval of Flyrcado (Flurpiridaz F 18) PET Radiotracer for Improved CAD Diagnosis

Top 20 Diagnostic Companies of 2024

Top 20 Diagnostics Companies Based on 2021 Revenue

Top 20 Diagnostics Companies Based on 2020 Revenue

Top 20 Diagnostics Companies Based on 2019 Revenue

Top 20 Medical Device Companies Based on 2019 Revenue

PharmaShots’ Key Highlights of Fourth Quarter 2019

Top 20 Diagnostics Companies Based On 2018 Revenue

Contact US

FOLLOW US